REAL-WORLD TREATMENT PATTERNS AND CLINICAL OUTCOMES IN PATIENTS WITH METASTATIC NSCLC AFTER RECEIVING FIRST-LINE PEMBROLIZUMAB WITH PEMETREXED/PLATINUM CHEMOTHERAPY IN THE US ONCOLOGY NETWORK

被引：0
|
作者：
Goldschmidt, Jerome [1 ]
Annavarapu, Srinivas [2 ]
Venkatasetty, Divea [2 ]
Santorelli, Melissa [3 ]
Burke, Thomas [3 ]
Pennell, Nathan [4 ]
机构：
[1] US Oncol Network, Blacksburg, VA USA
[2] Ontada, Irving, TX USA
[3] Merck & Co Inc, Rahway, NJ 07065 USA
[4] Cleveland Clin, Cleveland, OH 44106 USA
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2022年 / 10卷
关键词：
D O I：
10.1136/jitc-2022-SITC2022.0933
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
933
引用
收藏
页码：A974 / A975
页数：2
相关论文
共 50 条
  • [31] Real-World Treatment Patterns, Sequencing, and Outcomes in Patients with Locally Advanced or Metastatic Urothelial Carcinoma Receiving Avelumab First-Line Maintenance in the United States
    Moon, Helen H.
    Kearney, Mairead
    Mahmoudpour, Seyed Hamidreza
    Ike, Chiemeka
    Morris, Valerie
    Rava, Andrew
    Kim, Sonia
    Sun, Haiyan
    Boyd, Marley
    Gomez Rey, Gabriel
    [J]. CURRENT ONCOLOGY, 2024, 31 (09) : 5662 - 5676
  • [32] Pembrolizumab-combination therapy for previously untreated metastatic nonsquamous NSCLC: Real-world outcomes at US oncology practices
    Liu, Stephen V.
    Hu, Xiaohan
    Li, Yeran
    Zhao, Bin
    Burke, Thomas
    Velcheti, Vamsidhar
    [J]. FRONTIERS IN ONCOLOGY, 2022, 12
  • [33] Real-world treatment patterns and clinical outcomes with first-line therapy in patients with locally advanced/metastatic urothelial carcinoma by cisplatin-eligibility
    Morgans, Alicia K.
    Galsky, Matthew D.
    Wright, Phoebe
    Hepp, Zsolt
    Chang, Nancy
    Willmon, Candice L.
    Sesterhenn, Steve
    Liu, Yutong
    Sonpavde, Guru P.
    [J]. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2023, 41 (08) : 357e11 - 357e21
  • [34] Clinical Trial and Real-World Outcomes of Patients With Metastatic NSCLC in the Post-Platinum-Based Chemotherapy Failure Setting
    Soon, Yu Yang
    Furnback, Wesley
    Kim, Jin
    Chuang, Po-Ya
    Chavez, Gordon
    Proescholdt, Christina
    Koh, Cloe Ying Chee
    [J]. JTO CLINICAL AND RESEARCH REPORTS, 2023, 4 (11):
  • [35] Real-World Treatment Patterns and Outcomes in Patients With Advanced NSCLC Treated After Prior Chemotherapy and Immunotherapy
    Haggstrom, D.
    Mhatre, S. K.
    Chen, F.
    Gao, R.
    Carroll, C.
    Patel, R.
    Park, J.
    Descoteaux, A.
    Stokes, M.
    Daniel, D.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S409 - S409
  • [36] First-line treatment patterns among patients with metastatic pancreatic ductal adenocarcinoma in the real-world setting
    Dennen, Syvart
    Harton, Joanna
    Cockrum, Paul
    Kim, George P.
    MacEwan, Joanna P.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [37] Real-world first-line treatment patterns and outcomes in patients with locally advanced or metastatic urothelial carcinoma in the United States.
    Chen, Ronald C.
    Mucha, Lisa
    Nimke, David
    Young, Christopher
    Yang, Hongbo
    Liu, Qing
    Greatsinger, Alexandra
    Zhang, Adina
    Wright, Phoebe
    Quicquaro, Christina Marie
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [38] Real-world treatment modification of first-line axitinib plus pembrolizumab in patients with metastatic renal cell carcinoma (mRCC)
    Zakharia, Y.
    Thomaidou, D.
    Li, B.
    Siu, G.
    Levin, R.
    Vlahiotis, A.
    Zanotti, G.
    [J]. ANNALS OF ONCOLOGY, 2021, 32 : S1423 - S1424
  • [39] Impact of Baseline Clinical Biomarkers on Treatment Outcomes in Patients With Advanced NSCLC Receiving First-line Pembrolizumab-Based Therapy
    Joshi, Ishani
    Peravali, Monica
    Geng, Xue
    Rao, Suman
    Chen, Kevin Y.
    Veytsman, Irina
    Giaccone, Giuseppe
    Liu, Stephen, V
    Kim, Chul
    [J]. CLINICAL LUNG CANCER, 2022, 23 (05) : 438 - 445
  • [40] First-line treatment of metastatic NSCLC (mNSCLC) patients without actionable mutations in US community oncology clinical practice
    McKay, Caroline
    Arunachalam, Ashwini
    Burke, Thomas A.
    Cao, Xiting
    Abernethy, Amy P.
    Carbone, David Paul
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (07)
12345